A detailed history of Westend Capital Management, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Westend Capital Management, LLC holds 180 shares of NVO stock, worth $18,473. This represents 0.01% of its overall portfolio holdings.

Number of Shares
180
Previous 180 -0.0%
Holding current value
$18,473
Previous $26.2 Million 18.12%
% of portfolio
0.01%
Previous 0.01%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 12, 2024

BUY
$102.11 - $135.92 $18,379 - $24,465
180 New
180 $23.1 Million

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $232B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Westend Capital Management, LLC Portfolio

Follow Westend Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Westend Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Westend Capital Management, LLC with notifications on news.